February 15, 2018Open Access

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Together, our data provide compelling evidence on the functional interrelationship between mutated EGFR and FASN and that the fatty acid metabolism pathway is a candidate target for acquired TKI-resistant EGFR mutant NSCLC patients.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ali et al. (Thu,) studied this question.

synapsesocial.com/papers/69fc56cf2bd1d6a2a7dd9aba https://doi.org/https://doi.org/10.15252/emmm.201708313

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung2000 · 322 citations
2SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver2002 · 4,008 citations
3The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas2013 · 128 citations
4Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity2004 · 601 citations
5Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer2009 · 389 citations

Me gusta

Guardar

Ver artículo completo